Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Immunotherapy is widely regarded as a promising treatment for cancer. However, the immune effector phase suppression of tumor microenvironment (TME) and the generation of immune-related adverse events limit its application. Research indicates that sonodynamic therapy (SDT) can effectively activate antitumor immunity while killing tumor cells. SDT produces cytotoxic substances of tumors, and then cell apoptosis and immunogenic death occur by selectively activating the sonosensitizer under ultrasound. In recent years, various SDT alone as well as SDT in combination with other therapies have been developed to induce immunogenic cell death (ICD) and enhance immunotherapy. This paper overviews the research progress of SDT and nanotechnology in recent years, including the strategies involving SDT alone, SDT-based synergistic induction of antitumor immunity, and immunotherapy based on SDT for multimodal immunotherapy. Finally, the prospects and challenges of these SDT-based therapies in cancer immunotherapy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Localizing sonosensitizers to subcellular organelles is important because the lifespan and diffusion length of certain free radical products produced by sonosensitizers during SDT is relatively short [39, 44].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“approach to regulate T-cell activity to kill tumor cells through pathways such as co-inhibition or co-stimulatory signaling (63).”
BackgroundSiddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S. A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S. J., Scarpellino, L., Gfeller, D., Pradervand, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.021 · Cited by 1,679 · cited 1×
“In recent years, immunotherapy, as a new generation of anticancer therapy, has developed rapidly in clinical application, especially checkpoint blockade immunotherapy and chimeric antigen receptor T-cell immunotherapy, which has led to the significant development of clinical research direction (1, 2).”
BackgroundMultifunctional sonosensitizers in sonodynamic cancer therapy
Son, S., Kim, J. H., Wang, X., Zhang, C., Yoon, S. A., Shin, J., Sharma, A., Lee, M. H., Cheng, L., Wu, J., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00648f · Cited by 1,150 · cited 1×
“Conventional mechanisms have been accredited that reactive oxygen species produced by sonosensitizers and the cavitation effect induced by ultrasound irradiation act mainly during SDT (25).”
BackgroundDetection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138 · cited 1×
“However, with the tumor progressed and an immunosuppressive tumor microenvironment (TME) established, immunotherapy failed to drive an efficient immune response (3).”
BackgroundQian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Immunogenic cell death in cancer therapy: Present and emerging inducers
Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 719
Lan, G., Ni, K., Xu, Z., Veroneau, S. S., Song, Y., & Lin, W. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01072 · Cited by 662 · cited 1×
“Peptides targeting ER, such as pardaxin peptides, and decorated nanomaterials are expected to solve the problem (65).”
BackgroundEngineering CAR-T Cells for Next-Generation Cancer Therapy
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.005 · Cited by 639 · cited 1×
“In recent years, immunotherapy, as a new generation of anticancer therapy, has developed rapidly in clinical application, especially checkpoint blockade immunotherapy and chimeric antigen receptor T-cell immunotherapy, which has led to the significant development of clinical research direction (1, 2).”
BackgroundHuang, L., Li, Y., Du, Y., Zhang, Y., Wang, X., Ding, Y., Yang, X., Meng, F., Tu, J., Luo, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12771-9 · Cited by 596
Cited by
Nanomaterials Enhanced Sonodynamic Therapy for Multiple Tumor Treatment
Yang, M., Wang, X., Peng, M., Wang, F., Hou, S., Xing, R., & Chen, A. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01666-8 · Cited by 112
Small molecule sonosensitizers in cancer therapy: recent advances and clinical prospects
Li, D., Zhu, Y., Yin, W., Lin, X., Kim, G., Liu, Z., Jung, S., Seo, J., Kim, S., Kim, J. S., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00088b · Cited by 84
Elzoghby, A. O., Samir, O., Emam, H. E., Soliman, A., Abdelgalil, R. M., Elmorshedy, Y. M., Elkhodairy, K. A., & Nasr, M. L. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.022 · Cited by 58
“PDT and PTT can be combined together to enable synergistic phototherapy for enhancing ICD efficacy.”
BackgroundExosomes as drug delivery systems in glioma immunotherapy
Hao, X., Wang, S., Wang, L., Li, J., Li, Y., & Liu, J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02611-4 · Cited by 50
“Therapies such as radiotherapy, photodynamic therapy, photodynamic therapy (PDT), and oncolytic viruses can also cause apoptosis in tumor cells, resulting in the release of antigens and triggering ICD [163, 164].”
BackgroundNanosensitizer-assisted sonodynamic therapy for breast cancer
Yu, J., Hu, J.-R., Tian, Y., Lei, Y.-M., Hu, H.-M., Lei, B.-S., Zhang, G., Sun, Y., & Ye, H.-R. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03311-3 · Cited by 43
“Localizing sonosensitizers to subcellular organelles is important because the lifespan and diffusion length of certain free radical products produced by sonosensitizers during SDT is relatively short [39, 44].”
Metadata
- Authors
- Wang, T., Peng, W., Du, M., & Chen, Z.
- Affiliations
- First Affiliated Hospital of University of South China (CN)
- University of South China (CN)
- Corresponding author
- Du, Meng
- Chen, Zhiyi
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2023-04-24
- Volume
- 13
- Pages
- 1167105-1167105
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC10166230
- OpenAlex
- W4366827754
- Cited by
- 58
- References
- 66
- Citations by year
- 2026: 22 · 2025: 18 · 2024: 14 · 2023: 4
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82102087, 82272028, 82272028, 81971621, 82102087, 81971621)
- Natural Science Foundation of Guangdong Province (81971621, 2020A1515110628, 2021A1515011177)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- sonodynamic therapy, immunogenic cell death, antitumor immunity, tumor microenvironment, sonosensitizer, ultrasound, cancer immunotherapy, combination therapy, nanotechnology, immune-related adverse events
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity. https://app.cochat.ai/papers/10.3389/fonc.2023.1167105
- The paper
- Wang, T., Peng, W., Du, M., & Chen, Z. (2023). Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1167105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

